Fundamentals Hub
APTN ADAPTIN BIO, INC.
APTN financial statements, revenue, balance sheet, cash flow, and SEC filings
Showing 3 of 3 annual and 0 of 11 quarterly periods.
Full history available with a free account or via API.
▼ Company Profile
Filer Category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity Type
Operating
Public Float
$9.30M (Jun 2025)
Industry (SIC)
2836 Biological Products, (No Diagnostic Substances)
Incorporated
DE
Fiscal Year End
December (1231)
Phone
(888) 609-1498
EIN
881566415
Headquarters
CHARLOTTE, NC, 28277
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names:
Unite Acquisition 1 Corp. (2023–2025)
▼ Key Metrics (TTM)
As of Jun 30, 2026Financials
Revenue
-
Net Income
$-5.40M
Total Assets
$981.45K
Total Equity
$-1.67M
Total Debt
-
Free Cash Flow
-
Ratios
Return on Equity
324%
Return on Assets
-549.7%
Current Ratio
0.37x
Sources and calculation details
Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.
Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.
Annual (FY)
Quarterly 🔒
Chart 🔒
| Metric | FY2025 📄 | FY2024 📄 | FY2023 📄 |
|---|---|---|---|
| Income Statement | |||
| REVENUE | |||
| OPERATING EXPENSES | |||
| R&D Expense | $1.77M | $1.82M | - |
| SG&A Expense | $3.64M | $745.29K | $85.59K |
| Operating Income | $-5.41M | $-2.57M | $-85.59K |
| NON-OPERATING INCOME / EXPENSE | |||
| Other Income/Expense | $247.37K | $-552.67K | - |
| Pretax Income | $-5.17M | $-3.12M | - |
| Net Income | $-5.17M | $-3.12M | $-85.59K |
| PER SHARE & SUPPLEMENTAL | |||
| Diluted EPS | $-0.66 | $-0.96 | $-0.02 |
| Diluted Shares | 7.81M | 3.25M | 5.00M |
| Balance Sheet | |||
| ASSETS | |||
| Cash & Equivalents | $459.17K | $34.09K | $380 |
| Other Current Assets | $159.99K | $11.45K | - |
| Current Assets | $619.16K | $45.54K | $380 |
| Noncurrent Assets | $0 | $193.88K | $0 |
| Total Assets | $619.16K | $239.42K | $380 |
| LIABILITIES | |||
| Accounts Payable | $1.51M | $1.36M | $58 |
| Current Liabilities | $2.11M | $4.34M | $113.28K |
| Noncurrent Liabilities | $0 | $0 | $0 |
| Total Liabilities | $2.11M | $4.34M | $113.28K |
| EQUITY | |||
| Common Stock | $866 | $325 | $500 |
| Additional Paid-in Capital | $7.80M | $23.79K | - |
| Retained Earnings | $-9.29M | $-4.12M | $-113.40K |
| Total Equity | $-1.49M | $-4.10M | $-112.90K |
| Total Liabilities & Equity | $619.16K | $239.42K | $380 |
| SUPPLEMENTAL | |||
| Shares Outstanding | 8.66M | 3.25M | 5.00M |
| Check: A − (L + E + Temp. Equity) | - | - | - |
| Cash Flow Statement | |||
| Cash from Operations | $-4.78M | $-649.28K | $-81.04K |
| Capital Expenditures | - | - | - |
| Cash from Investing | $0 | $0 | $0 |
| Cash from Financing | $5.20M | $678.61K | $80.92K |
| Free Cash Flow | - | - | - |
| Beginning Cash (CFS) | $34.09K | $4.75K | $500 |
| Net Change in Cash | $425.09K | $29.33K | $-120 |
| Effect of FX on Cash | - | - | - |
| Calculated Ending Cash | $459.17K | $34.09K | $380 |
| Cash per BS | $459.17K | $34.09K | $380 |
| Cash scope difference (CFS − BS) | - | - | - |
| Cash per CFS | $459.17K | $34.09K | $380 |
Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.
Create Free Account Log In🔒
Quarterly data and charts require a free account
Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.
▼ Frequently Asked Questions
Is ADAPTIN BIO, INC. profitable?
No. ADAPTIN BIO, INC. reported $-5.40M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.